Compare · ROL vs SYRA
ROL vs SYRA
Side-by-side comparison of Rollins Inc. (ROL) and Syra Health Corp. (SYRA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ROL and SYRA operate in Diversified Commercial Services (Consumer Discretionary), so they compete in similar markets.
- ROL carries a market cap of $27.28B.
- Over the past year, ROL is up 1.1% and SYRA is up 0.0% - ROL leads by 1.1 points.
- ROL has hit the wire 6 times in the past 4 weeks while SYRA has been quiet.
- ROL has more recent analyst coverage (23 ratings vs 0 for SYRA).
- Company
- Rollins Inc.
- Syra Health Corp.
- Price
- $56.62-0.66%
- $0.18+42.31%
- Market cap
- $27.28B
- -
- 1M return
- +5.98%
- +0.00%
- 1Y return
- +1.11%
- +0.00%
- Industry
- Diversified Commercial Services
- Diversified Commercial Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2023
- News (4w)
- 6
- 0
- Recent ratings
- 23
- 0
Rollins Inc.
Rollins, Inc., through its subsidiaries, provides pest and termite control services to residential and commercial customers. It offers protection against termite damage, rodents, and insects to homes and businesses, including hotels, food service establishments, food manufacturers, retailers, and transportation companies. The company also provides pest management and sanitation services and products to the food and commodity industries; consulting services on border protection related to Australia's biosecurity program; and bird control and specialist services, as well as offers specialized services to mining, and oil and gas sectors. In addition, it offers mosquito control, wildlife, lawn care, insulation, and HVAC services. The company serves clients directly, as well as through franchisee operations in the United States, Canada, Australia, Europe, Asia, Central and South America, the Caribbean, the Middle East, and Africa. Rollins, Inc. was incorporated in 1948 and is headquartered in Atlanta, Georgia.
Latest ROL
- SEC Form 10-Q filed by Rollins Inc.
- Rollins Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- ROLLINS, INC. REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
- ROLLINS, INC. ANNOUNCES REGULAR QUARTERLY CASH DIVIDEND
- Loop Capital initiated coverage on Rollins with a new price target
- ROLLINS, INC. SCHEDULES DATE FOR RELEASE OF FIRST QUARTER 2026 FINANCIAL RESULTS
- The Woodworkers You Don't Want: Inside the World of Carpenter Ants with Orkin Canada
- SEC Form DEFA14A filed by Rollins Inc.
- SEC Form DEF 14A filed by Rollins Inc.
- Sotera Health Appoints Kenneth D. Krause to the Board of Directors
Latest SYRA
- Syra Health and Nora Mental Health Announce Telehealth Partnership to Expand Access to Mental and Behavioral Health Services Across Indiana
- SEC Form 10-K filed by Syra Health Corp.
- Syra Health Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Syra Health Posts Strong FY2025 Results with 157% Population Health Growth and 76% Net Loss Reduction: Targets Profitability by Year-End 2026
- Syra Health To Announce Fourth Quarter and Full Year 2025 Financial Results
- CEO Alexander Gregory R. was granted 110,537 units of Restricted Stock Units (SEC Form 4)
- SEC Form 3 filed by new insider Alexander Gregory R.
- SEC Form 3 filed by new insider Mereddy Radhika
- Syra Health Corp. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits
- Syra Health Appoints Healthcare Executive and Former U.S. Marine Gregory R. Alexander as Chief Executive Officer to Drive Growth